Warning

The following pages contain information relating to BioAlliance Pharma, in anticipation of a public offering in France and listing on the Eurolist market of Euronext Paris of its shares. The dissemination of all or any part of this information may, in other countries, be covered by specific laws and regulations. No measures have been taken to allow a public offering of shares of BioAlliance Pharma in any country other than France. The information in the following pages may not be transmitted and cannot constitute an offer of subscription or sale of shares in the countries where such an offer would violate applicable laws and regulations, including Australia, Canada, Japan and the United States of America.

Persons taking note of this information must inform themselves about these possible local restrictions and conform to them, and abstain from introducing or distributing this information in any countries, where to do so would violate of applicable laws and regulations. BioAlliance Pharma accepts no responsibility for any violation of applicable securities laws and regulations by a third-party, and disclaims any obligation to update the information provided herein.

In particular, the shares of BioAlliance Pharma have not and will not be registered in the United States of America within the meaning of the Securities Act of 1933 as amended and will not be the subject of a public offering in the United States of America. Consequently, this information may not be used for any offer or sale of shares in the United States of America unless such offer or sale is exempt from all applicable registration obligations. No communication relating to this public offering may be addressed to the United States of America or target the citizens of or persons residing or present in the United States of America.

CLICK HERE TO CONFIRM THAT YOU ARE AWARE OF AND AGREE TO BE BOUND BY THESE RESTRICTIONS AND.THAT YOU ARE NOT A CITIZEN OR RESIDENT OF AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OF AMERICA.